ZBNA
CYTK icon

Zions Bancorporation, National Association’s Cytokinetics CYTK Stock Holding History

Zions Bancorporation, National Association’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.12K Buy
107
+11
+11% +$790 ﹤0.01% 934
2026
Q1 		$6.33K Buy
96
+77
+405% +$4.89K ﹤0.01% 948
2025
Q4 		$1.21K Buy
+19
New +$1.18K ﹤0.01% 1056

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zions Bancorporation, National Association's CYTK Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Cytokinetics (CYTK) stake by 11% in Q2 2026, buying an estimated $790 and bringing the position to 107 shares worth $9.12K. The position accounts for ﹤0.01% of the portfolio, ranked #934.

Zions Bancorporation, National Association first reported a position in CYTK in Q4 2025 and has held it in 3 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Zions Bancorporation, National Association held 107 shares of Cytokinetics worth $9.12K as of Q2 2026.
  • Zions Bancorporation, National Association bought 11 Cytokinetics shares in Q2 2026, an estimated $790.
  • Cytokinetics made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #934 holding.
  • Zions Bancorporation, National Association first reported a position in Cytokinetics in Q4 2025 and has held it in 3 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.